Literature DB >> 26666778

Promising bifunctional chelators for copper 64-PET imaging: practical (64)Cu radiolabeling and high in vitro and in vivo complex stability.

Ningjie Wu1, Chi Soo Kang1, Inseok Sin1, Siyuan Ren1, Dijie Liu2, Varyanna C Ruthengael2, Michael R Lewis3,2, Hyun-Soon Chong4.   

Abstract

Positron emission tomography (PET) using copper-64 is a sensitive and non-invasive imaging technique for diagnosis and staging of cancer. A bifunctional chelator that can present rapid radiolabeling kinetics and high complex stability with (64)Cu is a critical component for targeted PET imaging. Bifunctional chelates 3p-C-NE3TA, 3p-C-NOTA, and 3p-C-DE4TA were evaluated for complexation kinetics and stability with (64)Cu in vitro and in vivo. Hexadentate 3p-C-NOTA and heptadentate 3p-C-NE3TA possess a smaller TACN-based macrocyclic backbone, while nonadentate 3p-C-DE4TA is constructed on a larger CYCLEN-based ring. The frequently explored chelates of (64)Cu, octadentate C-DOTA and hexadentate C-NOTA were also comparatively evaluated. Radiolabeling kinetics of bifunctional chelators with (64)Cu was assessed under mild conditions. All bifunctional chelates instantly bound to (64)Cu in excellent radiolabeling efficiency at room temperature. C-DOTA was less efficient in binding (64)Cu than all other chelates. All (64)Cu-radiolabeled bifunctional chelates remained stable in human serum without any loss of (64)Cu for 2 days. When challenged by an excess amount of EDTA, (64)Cu complexes of C-NOTA, 3p-C-NE3TA and 3p-C-NOTA were shown to be more stable than (64)Cu-C-DOTA and (64)Cu-3p-C-DE4TA. (64)Cu complexes of the new chelates 3p-C-NE3TA and 3p-C-NOTA displayed comparable in vitro and in vivo complex stability to (64)Cu-C-NOTA. In vivo biodistribution result indicates that the (64)Cu-radiolabeled complexes of 3p-C-NOTA and 3p-C-NE3TA possess excellent in vivo complex stability, while (64)Cu-3p-C-DE4TA was dissociated as evidenced by high renal and liver retention in mice. The results of in vitro and in vivo studies suggest that the bifunctional chelates 3p-C-NE3TA and 3p-C-NOTA offer excellent chelation chemistry with (64)Cu for potential PET imaging applications.

Entities:  

Keywords:  Bifunctional chelator; Cu-64; Pet imaging

Mesh:

Substances:

Year:  2015        PMID: 26666778      PMCID: PMC5116241          DOI: 10.1007/s00775-015-1318-7

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  26 in total

1.  Synthesis of novel 1,4,7-triazacyclononane-N,N',N"-triacetic acid derivatives suitable for protein labeling.

Authors:  M Studer; C F Meares
Journal:  Bioconjug Chem       Date:  1992 Jul-Aug       Impact factor: 4.774

Review 2.  Molecular imaging of cancer with positron emission tomography.

Authors:  Sanjiv Sam Gambhir
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

3.  Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.

Authors:  Xiankai Sun; Melinda Wuest; Gary R Weisman; Edward H Wong; David P Reed; C Andrew Boswell; Ramunas Motekaitis; Arthur E Martell; Michael J Welch; Carolyn J Anderson
Journal:  J Med Chem       Date:  2002-01-17       Impact factor: 7.446

4.  In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.

Authors:  L A Bass; M Wang; M J Welch; C J Anderson
Journal:  Bioconjug Chem       Date:  2000 Jul-Aug       Impact factor: 4.774

Review 5.  Copper chelation chemistry and its role in copper radiopharmaceuticals.

Authors:  T J Wadas; E H Wong; G R Weisman; C J Anderson
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Molecular imaging with copper-64.

Authors:  Suzanne V Smith
Journal:  J Inorg Biochem       Date:  2004-11       Impact factor: 4.155

7.  Complexing mechanism of the lanthanide cations Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (dota)-characterization of three successive complexing phases: study of the thermodynamic and structural properties of the complexes by potentiometry, luminescence spectroscopy, and EXAFS.

Authors:  Juliette Moreau; Emmanuel Guillon; Jean-Claude Pierrard; Jean Rimbault; Marc Port; Michel Aplincourt
Journal:  Chemistry       Date:  2004-10-11       Impact factor: 5.236

8.  Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

Authors:  C Andrew Boswell; Xiankai Sun; Weijun Niu; Gary R Weisman; Edward H Wong; Arnold L Rheingold; Carolyn J Anderson
Journal:  J Med Chem       Date:  2004-03-11       Impact factor: 7.446

9.  [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.

Authors:  Adam F Prasanphanich; Prasant K Nanda; Tammy L Rold; Lixin Ma; Michael R Lewis; Jered C Garrison; Timothy J Hoffman; Gary L Sieckman; Said D Figueroa; Charles J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-12       Impact factor: 11.205

Review 10.  Clinical applications of PET in oncology.

Authors:  Eric M Rohren; Timothy G Turkington; R Edward Coleman
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

View more
  14 in total

1.  ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.

Authors:  Christopher G England; Dawei Jiang; Reinier Hernandez; Haiyan Sun; Hector F Valdovinos; Emily B Ehlerding; Jonathan W Engle; Yunan Yang; Peng Huang; Weibo Cai
Journal:  Mol Pharm       Date:  2017-09-06       Impact factor: 4.939

2.  64Cu-labeled melanin nanoparticles for PET/CT and radionuclide therapy of tumor.

Authors:  Huijun Zhou; Qing Zhang; Yan Cheng; Lili Xiang; Guohua Shen; Xiaoai Wu; Huawei Cai; Daifeng Li; Hua Zhu; Ruiping Zhang; Lin Li; Zhen Cheng
Journal:  Nanomedicine       Date:  2020-06-20       Impact factor: 5.307

3.  Site-Specific Immuno-PET Tracer to Image PD-L1.

Authors:  Haley L Wissler; Emily B Ehlerding; Zhigang Lyu; Yue Zhao; Si Zhang; Anisa Eshraghi; Zakey Yusuf Buuh; Jeffrey C McGuth; Yifu Guan; Jonathan W Engle; Sarah J Bartlett; Vincent A Voelz; Weibo Cai; Rongsheng E Wang
Journal:  Mol Pharm       Date:  2019-03-25       Impact factor: 4.939

4.  Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation.

Authors:  Marianna Tosato; Marco Verona; Chiara Favaretto; Marco Pometti; Giordano Zanoni; Fabrizio Scopelliti; Francesco Paolo Cammarata; Luca Morselli; Zeynep Talip; Nicholas P van der Meulen; Valerio Di Marco; Mattia Asti
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

5.  Evaluation of Pan-SSTRs Targeted Radioligand [64Cu]NOTA-PA1 Using Micro-PET Imaging in Xenografted Mice.

Authors:  Fei Liu; Xiaoyi Guo; Teli Liu; Xiaoxia Xu; Nan Li; Chiyi Xiong; Chun Li; Hua Zhu; Zhi Yang
Journal:  ACS Med Chem Lett       Date:  2020-02-12       Impact factor: 4.345

6.  Site-specific antibody fragment conjugates for targeted imaging.

Authors:  Robert Maloney; Zakey Yusuf Buuh; Yue Zhao; Rongsheng E Wang
Journal:  Methods Enzymol       Date:  2020-03-31       Impact factor: 1.600

7.  Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with 177Lu(III) and 90Y(III) for radiopharmaceutical applications: Synthesis, DFT calculation, radiolabeling, and in vitro complex stability.

Authors:  Hyun-Soon Chong; Yunwei Chen; Chi Soo Kang; Inseok Sin; Shuyuan Zhang; Haixing Wang
Journal:  J Inorg Biochem       Date:  2021-04-24       Impact factor: 4.336

8.  [64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model.

Authors:  Andreas Poschenrieder; Margret Schottelius; Theresa Osl; Markus Schwaiger; Hans-Jürgen Wester
Journal:  EJNMMI Radiopharm Chem       Date:  2017-01-19

9.  Imaging Neurotensin Receptor in Prostate Cancer With 64Cu-Labeled Neurotensin Analogs.

Authors:  Huaifu Deng; Hui Wang; He Zhang; Mengzhe Wang; Ben Giglio; Xiaofen Ma; Guihua Jiang; Hong Yuan; Zhanhong Wu; Zibo Li
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

Review 10.  New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.

Authors:  Anna Lucia Tornesello; Luigi Buonaguro; Maria Lina Tornesello; Franco Maria Buonaguro
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.